Role of cannabis and endocannabinoids in the genesis of schizophrenia
- 24 July 2009
- journal article
- review article
- Published by Springer Nature in Psychopharmacology
- Vol. 206 (4) , 531-549
Abstract
Cannabis abuse and endocannabinoids are associated to schizophrenia.Keywords
This publication has 183 references indexed in Scilit:
- Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in ratsNeuropharmacology, 2008
- Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to SchizophreniaBiological Psychiatry, 2008
- Sensory gating and its modulation by cannabinoids: electrophysiological, computational and mathematical analysisCognitive Neurodynamics, 2008
- Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humansPsychopharmacology, 2008
- Impact of substance use on the onset and course of early psychosisSchizophrenia Research, 2005
- Association of Dopamine Transporter Loss in the Orbitofrontal and Dorsolateral Prefrontal Cortices With Methamphetamine-Related Psychiatric SymptomsAmerican Journal of Psychiatry, 2003
- Effect of Clozapine on Caudate Nucleus Volume in Relation to Symptoms of SchizophreniaAmerican Journal of Psychiatry, 2001
- Involvement of Dopamine Receptors in the Antipsychotic Profile of (−) EticlopridePhysiology & Behavior, 1997
- Cannabis and the BrainAustralian & New Zealand Journal of Psychiatry, 1996
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964